Northern Trust Corp Next Cure, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Next Cure, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 47,562 shares of NXTC stock, worth $39,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,562

Previous 47,562 -0.0%

Holding current value

$39,476

Previous $75,000 13.33%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.17 - $2.49 $16,164 - $34,401	13,816 Added 40.94%	47,562 $75,000
Q1 2024 May 14, 2024	BUY	$1.13 - $2.23 $838 - $1,654	742 Added 2.25%	33,746 $75,000
Q4 2023 Feb 13, 2024	SELL	$1.03 - $1.45 $10,310 - $14,514	-10,010 Reduced 23.27%	33,004 $37,000
Q3 2023 Nov 13, 2023	SELL	$1.29 - $1.84 $593 - $846	-460 Reduced 1.06%	43,014 $55,000
Q2 2023 Aug 11, 2023	BUY	$1.47 - $1.86 $676 - $855	460 Added 1.07%	43,474 $78,000
Q1 2023 May 15, 2023	BUY	$1.46 - $1.83 $248 - $311	170 Added 0.4%	43,014 $63,000
Q4 2022 Feb 13, 2023	SELL	$1.2 - $3.07 $657 - $1,682	-548 Reduced 1.26%	42,844 $60,000
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.19 $2,777 - $5,298	1,021 Added 2.41%	43,392 $119,000
Q2 2022 Aug 12, 2022	SELL	$3.38 - $5.27 $1,504 - $2,345	-445 Reduced 1.04%	42,371 $199,000
Q1 2022 May 13, 2022	SELL	$4.76 - $6.24 $4,940 - $6,477	-1,038 Reduced 2.37%	42,816 $208,000
Q4 2021 Feb 08, 2022	BUY	$5.7 - $9.1 $9,239 - $14,751	1,621 Added 3.84%	43,854 $263,000
Q3 2021 Nov 15, 2021	BUY	$6.74 - $8.02 $20,260 - $24,108	3,006 Added 7.66%	42,233 $285,000
Q2 2021 Aug 13, 2021	SELL	$7.6 - $10.28 $1.12 Million - $1.51 Million	-146,796 Reduced 78.91%	39,227 $316,000
Q1 2021 May 12, 2021	SELL	$9.81 - $13.88 $190,461 - $269,480	-19,415 Reduced 9.45%	186,023 $1.86 Million
Q4 2020 Feb 11, 2021	SELL	$9.47 - $12.43 $47,709 - $62,622	-5,038 Reduced 2.39%	205,438 $2.24 Million
Q3 2020 Nov 16, 2020	SELL	$8.15 - $21.17 $143,008 - $371,469	-17,547 Reduced 7.7%	210,476 $1.85 Million
Q2 2020 Aug 14, 2020	BUY	$21.19 - $40.2 $1.21 Million - $2.29 Million	56,970 Added 33.31%	228,023 $4.89 Million
Q1 2020 May 14, 2020	BUY	$32.32 - $58.37 $159,240 - $287,588	4,927 Added 2.97%	171,053 $6.34 Million
Q4 2019 Feb 14, 2020	BUY	$25.0 - $92.22 $2.92 Million - $10.8 Million	116,601 Added 235.44%	166,126 $9.36 Million
Q3 2019 Nov 13, 2019	BUY	$15.73 - $41.6 $425,433 - $1.13 Million	27,046 Added 120.32%	49,525 $1.53 Million
Q2 2019 Aug 13, 2019	BUY	$14.16 - $20.64 $318,302 - $463,966	22,479 New	22,479 $337,000

Others Institutions Holding NXTC

# of Institutions

Shares Held

15.9M

Call Options Held

Put Options Held

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $23M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Next Cure, Inc. Transaction History